La bourse est fermée

Edwards Lifesciences Corporation (EW)

NYSE - Nasdaq Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
88,64+0,89 (+1,01 %)
À partir de 12:29PM EDT. Marché ouvert.

Edwards Lifesciences Corporation

One Edwards Way
Irvine, CA 92614
United States
949 250 2500
https://www.edwards.com

Secteur(s)Healthcare
Secteur d’activitéMedical Devices
Employés à temps plein19 800

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Bernard J. ZovighianCEO & Director2,27MS.O.1968
Mr. Scott B. UllemCorporate VP & CFO1,35M6,36M1967
Mr. Donald E. Bobo Jr.Corporate Vice President of Strategy & Corporate Development1,27M2,68M1962
Mr. Larry L. WoodCorporate VP and Group President of TAVR & Surgical Structural Heart1,49M2,13M1966
Dr. Todd J. Brinton FACC, M.D.Corporate VP of Advanced Technology & Chief Scientific OfficerS.O.S.O.S.O.
Mark WilterdingVice President of Investor RelationsS.O.S.O.S.O.
Mr. Arnold A. PinkstonCorporate VP & General CounselS.O.S.O.1959
Mr. Dirksen J. LehmanCorporate Vice President of Public AffairsS.O.S.O.S.O.
Ms. Christine Z. McCauleyCorporate Vice President of Human ResourcesS.O.S.O.1965
Mr. Gary I. SorsherSenior Vice President of Quality & Regulatory ComplianceS.O.S.O.1965
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Edwards Lifesciences Corporation en date du 1 avril 2024 est 3. Les scores principaux sont Audit : 4; Société : 5; Droits des actionnaires : 4; Compensation : 3.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.